ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,272.32
      -0.21%
      US Tech 100
      18,078.00
      -0.26%
      Dow Jones
      38,569.67
      0.00%
      Brent Oil
      77.435
      -0.90%
      Bitcoin
      71,024.75
      3.23%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Halozyme Therapeutics (HTI)

      7. Halozyme Therapeutics (HTI) News

      HTI

      Halozyme Therapeutic (HTI)

      Halozyme Therapeutics
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:HTI
      DateTimeSourceHeadlineSymbolCompany
      1:08PMiHub NewswireFeaturedElement79 Gold Corp Continues Fostering Local Community Engagement
      05/07/20079:00AMPR Newswire (US)Halozyme Therapeutics to Hold Business Update Conference Call on May 11AMEX:HTIHalozyme Therapeutics
      05/02/20079:00AMPR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
      05/02/20079:00AMPR Newswire (US)Halozyme Therapeutics to Present at May Investment ConferencesAMEX:HTIHalozyme Therapeutics
      04/30/20079:00AMPR Newswire (US)Halozyme Therapeutics Announces Nasdaq Global Market Listing ApprovalAMEX:HTIHalozyme Therapeutics
      04/27/200710:00AMPR Newswire (US)Baxter Introduces HYLENEX for Use in Ophthalmic SurgeryAMEX:HTIHalozyme Therapeutics
      04/24/20079:00AMPR Newswire (US)Halozyme Therapeutics Announces $32.1 Million Private FinancingAMEX:HTIHalozyme Therapeutics
      03/13/20076:00PMPR Newswire (US)Halozyme Therapeutics Adopts SEC Rule 10b5-1 PolicyAMEX:HTIHalozyme Therapeutics
      03/08/20078:00AMPR Newswire (US)Halozyme Therapeutics Reports Fourth Quarter and Year End 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
      03/07/20078:00AMPR Newswire (US)Halozyme Therapeutics to Present at the Cowen & Company 27th Annual Health Care ConferenceAMEX:HTIHalozyme Therapeutics
      03/06/20078:00AMPR Newswire (US)Halozyme Therapeutics to Hold 2006 Fourth Quarter and Year End Conference Call on March 8AMEX:HTIHalozyme Therapeutics
      02/14/20074:31PMPR Newswire (US)Halozyme Therapeutics and Baxter Present Promising Results for the Use of HYLENEX From the Infuse-Morphine StudyAMEX:HTIHalozyme Therapeutics
      02/14/20078:00AMPR Newswire (US)Halozyme and Baxter Expand Global HYLENEX CollaborationAMEX:HTIHalozyme Therapeutics
      02/13/20078:00AMPR Newswire (US)Halozyme therapeutics to Present at the Roth Capital Partners 19th Annual OC ConferenceAMEX:HTIHalozyme Therapeutics
      01/22/20078:00AMPR Newswire (US)Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large PrAMEX:HTIHalozyme Therapeutics
      01/03/20078:00AMPR Newswire (US)Halozyme Therapeutics to Present at the JPMorgan 25th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
      12/05/20065:48PMPR Newswire (US)Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug DeliveryAMEX:HTIHalozyme Therapeutics
      11/27/20068:00AMPR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
      11/27/20068:00AMPR Newswire (US)Halozyme Therapeutics Completes Enrollment of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a LargAMEX:HTIHalozyme Therapeutics
      11/20/20068:00AMPR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
      11/20/20068:00AMPR Newswire (US)Halozyme Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences ConferenceAMEX:HTIHalozyme Therapeutics
      11/09/20064:05PMPR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
      11/09/20064:05PMPR Newswire (US)Halozyme Therapeutics Reports Third Quarter 2006 Financial ResultsAMEX:HTIHalozyme Therapeutics
      11/08/20064:00PMPR Newswire (US)Halozyme Therapeutics Names William Fallon Vice President, Manufacturing & OperationsAMEX:HTIHalozyme Therapeutics
      11/01/20061:55PMPR Newswire (US)Halozyme Therapeutics to Present at the Rodman and Renshaw 8th Annual Healthcare ConferenceAMEX:HTIHalozyme Therapeutics
      10/26/20069:00AMPR Newswire (US)New Survey Reveals Most Patients Are Unaware That Slaughterhouse-Derived Animal Products Are Used in a Majority of IVF ProcedureAMEX:HTIHalozyme Therapeutics
      10/12/20069:00AMPR Newswire (US)Halozyme Therapeutics to Present at the 2006 Bio InvestorForumAMEX:HTIHalozyme Therapeutics
      10/10/20069:00AMPR Newswire (US)Halozyme Therapeutics Completes Enrollment of Infuse-Morphine Clinical TrialAMEX:HTIHalozyme Therapeutics
      09/19/20069:00AMPR Newswire (US)Halozyme Therapeutics to Present at the Noble Financial Small Cap ConferenceAMEX:HTIHalozyme Therapeutics
      09/13/20069:00AMPR Newswire (US)Halozyme Therapeutics Completes Call of Second Tranche of Warrants From January 2004 FinancingAMEX:HTIHalozyme Therapeutics
       Showing the most relevant articles for your search:AMEX:HTI